The Disease
Pathology
Signs & Symptoms
Risk Factors
Early Onset
Dementia
Women & Alzheimer’s
Detection
Stats & Costs
The Research
Areas of Focus
Alzheimer’s Genome Project
Genes to Therapy / Stem Cell Screening
Identification
Immune System Structures & Processes
Interaction of the Microbiome
Pathological Pathways & Systems
Therapeutic Strategies & Drug Discovery
Whole Genome Sequencing
Other Areas of Investigation
Consortia
ALZHEIMER’S DISEASE TAU CONSORTIUM
APOE CONSORTIUM
BRAIN ENTRY & EXIT CONSORTIUM
CIRCUITS CONSORTIUM (ENDED)
MICROBIOME CONSORTIUM
NEUROIMMUNE CONSORTIUM
Funded Projects
Grant Process
Our Researchers
Topics of Interest
Alzheimer’s in a Dish
Amyloid Hypothesis
Amyloid Precursor Protein
Brain Lymphatic System
Innate Immunity
Microglia
Blood Brain Barrier
Published Papers
Discoveries
About Us
Our Story
Our People
Reports
Giving
Donate
Ways to Donate
Planned Giving
CRYPTOCURRENCY
Our Heroes
In Memory & In Honor
Artists Giving Back
Charity Watchdogs
News and Events
Events
2018 Symposium Video
Webinars
Interviews
Press
Videos
Research Newsletter
December 2021
Fall 2020
March 2020
November 2019
October 2019
July 2019
March 2019
January 2019
November 2018
Blog
Awareness
The Face of Alzheimer’s
Better Your Brain
World Alzheimer’s Day
Dr. Solomon Carter Fuller
Contact
781-237-3800
Donate
Contact
Search
Rudy Tanzi, PH.D.: Repurposing Existing Drugs for use in Alzheimer’s Disease
Posted April 25, 2017
Drug Discovery
Videos
Rudy Tanzi, Ph.D.: Discussions on PICALM and the Importance of Collaboration
Back to News and Events
Rudy Tanzi, PH.D.: New Approaches in Alzheimer’s Disease Research
Related Content:
Rudy Tanzi, PH.D.: Repurposing Existing Drugs for use in Alzheimer’s Disease
“Alzheimer’s Outlook Far From Bleak”: JAMA Interview With Tanzi, Zlokovic
Promising New Alzheimer’s Drug Validates Anti-Amyloid Approach
Alzstream™ Webinar: From Genes to Therapies
Featured Researcher: Charles G. Glabe, Ph.D.
The State of Alzheimer’s Research, 2014
